Patent Yard Sign in
Expired Canadian patentCanada

Method for producing interleukin-1 receptor antagonists, a therapeutic activity protein, from body fluids

CA 2364386 C · Owner: Reinecke, Julio · Inventors: Wehling, Peter; Meijer, Hans; Reinecke, Julio

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention relates to a method for producing a prophylactically or therapeutically active protein, the syringe being filled with a body fluid and incubated, and the prophylactically or therapeutically active protein subsequently being formed in the body fluid.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed January 31, 2000 and granted December 6, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 31, 2020.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 31, 2022.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJanuary 31, 2000
GrantedDecember 6, 2011
Term endedJanuary 31, 2020
Patent numberCA 2364386 C
Classification (IPC)C07K14/54 +2 more

Timeline

Timeline From CIPO dates

2001200320052007200920112013201520172019Application filedJan 31, 2000Patent grantedDec 6, 2011Term endedJan 31, 2020

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.